ESG vs Robotic Sleeve Gastrectomy

ESG and sleeve gastrectomy differ in invasiveness, expected weight loss, risks, reversibility, and follow-up needs. Reflux history is one of the factors reviewed before either is chosen.

Sleeve gastrectomy removes roughly seventy five to eighty percent of the stomach, including the fundus, which lowers the hunger hormone ghrelin. The effect is both restrictive and hormonal, not purely mechanical.

In endoscopic sleeve gastroplasty, or ESG, you are sedated. A scope goes through the mouth into the stomach. A suturing device placed at the tip of the scope lays a series of stitches along the greater curve, drawing the stomach inward so it holds less and empties more slowly. Discharge timing and return to work depend on the procedure and your recovery.

In sleeve gastrectomy you are under general anesthesia. Several small ports are placed in the abdomen. The surgeon divides the stomach along a sizing tube and removes the outer portion, which is taken out through one of the port sites. The remaining stomach is a narrow tube.

Recovery from ESG varies by patient. Cramping, nausea, and a full feeling are common for a few days. Return to work and activity is individualized, and there is no abdominal wall incision to heal.

Recovery from sleeve gastrectomy takes longer. The incisions are small but real, and there are lifting restrictions while they heal. Both procedures follow a staged diet that starts with liquids and moves through soft foods before regular texture returns.

Sleeve gastrectomy changes anatomy permanently. It is the more established option when diabetes, sleep apnea, or fatty liver disease are part of the decision.

ESG sutures are internal and can loosen over time. Some people maintain their result for years. Some need a touch-up or move on to a different approach. Neither path is a failure. It is a reason to plan follow-up from the beginning rather than treating either procedure as a single event.

ESG does not remove tissue and preserves the fundus, so it is potentially reversible and can be revised. It does not close doors. If your health changes and a surgical option becomes the better answer later, that conversation is still available.

Sleeve gastrectomy removes stomach tissue and cannot be undone. It can be revised in specific circumstances, but the starting point is different.

Start with what you are treating. If the goal is to address metabolic disease that is already causing damage, an operation deserves serious consideration. If you are earlier in the picture, or you cannot take an extended recovery, or you want a step that does not remove tissue, ESG may fit better.

Coverage also shapes the decision in practice. Metabolic surgery is often handled through insurance. ESG has historically been self pay because most insurers treated it as investigational. As of January 2026 it has a permanent billing code, and a small but growing number of payers have begun to cover it. Coverage is still inconsistent, so benefits are verified individually and many patients continue to choose self pay. That is a real factor and it is worth understanding before you choose.

This page is educational. It is not medical advice and it does not replace an evaluation. What is right for you depends on your history, your testing, and a conversation with a surgeon.